Viewing Study NCT05268068


Ignite Creation Date: 2025-12-24 @ 5:42 PM
Ignite Modification Date: 2026-01-02 @ 10:13 AM
Study NCT ID: NCT05268068
Status: COMPLETED
Last Update Posted: 2022-03-07
First Post: 2022-03-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Intravenously (IV) Infused or Subcutaneously (SC) Injected Risankizumab in Healthy Adult Participants in China
Sponsor: AbbVie
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module